OUR EXPERIENCE WITH LASER PHOTOCOAGULATION IN DIABETIC MACULAR OEDEMA

Area of Science:

• Ophthalmology
• Diabetology

Background:

• Diabetic retinopathy is a leading cause of vision loss.
• Diabetic macular edema (DME), focal or diffuse, is the primary driver of visual impairment in diabetic retinopathy.
• The optimal timing for photocoagulation treatment in DME has been a subject of debate.

Purpose of the Study:

• To evaluate the efficacy of argon green macular grid photocoagulation in treating diabetic macular edema.
• To compare visual outcomes between treated eyes and control eyes in patients with DME.

Main Methods:

• A randomized clinical study involving 80 patients with diabetic macular edema.
• Treated group: 80 eyes underwent argon green macular grid photocoagulation.
• Control group: 80 eyes served as untreated controls.

Main Results:

• Vision improved in 5% of treated eyes.
• Vision deterioration occurred in 6.3% of treated eyes.
• Vision deterioration occurred in 16.3% of control eyes.

Conclusions:

• Laser photocoagulation plays a significant role in halting the progression of diabetic maculopathy.
• Early intervention with photocoagulation is recommended for clinically significant macular edema in diabetic patients.